Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Oncology|October 11, 2008
Impact of preexisting pulmonary fibrosis detected on chest radiograph and CT on the development of gefitinib-related interstitial lung diseaseYoichi Naito, Satoshi Tsuchiya, Shinichi Ishihara, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancerYoshio Tomizawa, Hironobu Iijima, Taisuke Nomoto, et al.
American Journal of Clinical Oncology|February 7, 2007
A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancerKyoichi Kaira, Satoshi Tsuchiya, Noriaki Sunaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2002
Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibilityNoriaki Sunaga, Takashi Kohno, Noriko Yanagitani, et al.
Anti-Cancer Drugs|March 5, 2005
Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancerKyoichi Kaira, Atsushi Takise, Koichi Minato, et al.
Physical Review Letters|May 20, 2014
Gapless quantum spin liquid in an organic spin-1/2 triangular-lattice κ-H3(Cat-EDT-TTF)2Takayuki Isono, Hiromichi Kamo, Akira Ueda, et al.
Physical Review Letters|September 10, 2011
Flow of a single magnetic vortex in a submicron-size superconducting Al disk controlled by radio-frequency currentsAtsushi Harada, Kengo Enomoto, Yamaguchi Takahide, et al.
American Journal of Clinical Oncology|October 9, 2007
Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancerNoriko Yanagitani, Satoshi Tsuchiya, Kyoichi Kaira, et al.
Chemical Communications (Cambridge, England)|July 24, 2012
In silico design, synthesis and evaluation of 3'-O-benzylated analogs of salacinol, a potent α-glucosidase inhibitor isolated from an Ayurvedic traditional medicine "Salacia"Genzoh Tanabe, Shinya Nakamura, Nozomi Tsutsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306Ikuo Sekine, Yutaka Nishiwaki, Takashi Ogino, et al.
Pageof 7